Cargando…
Structure-based discovery of CFTR potentiators and inhibitors
The cystic fibrosis transmembrane conductance regulator (CFTR) is a crucial ion channel whose loss of function leads to cystic fibrosis, while its hyperactivation leads to secretory diarrhea. Small molecules that improve CFTR folding (correctors) or function (potentiators) are clinically available....
Autores principales: | Liu, Fangyu, Kaplan, Anat Levit, Levring, Jesper, Einsiedel, Jürgen, Tiedt, Stephanie, Distler, Katharina, Omattage, Natalie S., Kondratov, Ivan S., Moroz, Yurii S., Pietz, Harlan L., Irwin, John J., Gmeiner, Peter, Shoichet, Brian K., Chen, Jue |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10515777/ https://www.ncbi.nlm.nih.gov/pubmed/37745391 http://dx.doi.org/10.1101/2023.09.09.557002 |
Ejemplares similares
-
CFTR function, pathology and pharmacology at single-molecule resolution
por: Levring, Jesper, et al.
Publicado: (2023) -
Author Correction: CFTR function, pathology and pharmacology at single-molecule resolution
por: Levring, Jesper, et al.
Publicado: (2023) -
Molecular structure of the ATP-bound, phosphorylated human CFTR
por: Zhang, Zhe, et al.
Publicado: (2018) -
Ultra-large library docking for discovering new chemotypes
por: Lyu, Jiankun, et al.
Publicado: (2019) -
An Update on CFTR Drug Discovery: Opportunities and Challenges
por: D’Ursi, Pasqualina, et al.
Publicado: (2022)